Financial News

Lucid Capital Markets Establishes Healthcare Equity Research Group with the Addition of Christopher Liu, PharmD, and Dev Prasad, Ph.D.

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Lucid Capital Markets, LLC (“Lucid”), a full-service investment bank, is pleased to announce two key additions to its healthcare equity research team with the hiring of Christopher Liu, PharmD, as Managing Director and Dev Prasad, Ph.D., MBA, as Senior Vice President. Both Christopher and Dev will be responsible for covering various therapeutic areas across the healthcare sector.

Christopher joins Lucid with over seven years of equity research experience with a specialization in oncology. Most recently, Christopher was a Director at Leerink Partners covering the oncology space. Prior to Leerink, Christopher was part of the biotechnology equity research teams at Canaccord Genuity and Oppenheimer. Christopher received his Doctor of Pharmacy from Rutgers University's Ernest Mario School of Pharmacy.

Dev brings ~four years of experience in equity research to Lucid specializing in inflammation and immunology. Prior to joining Lucid, Dev was a member of the equity research teams at Jefferies and JMP Securities. Before his transition into equity research, Dev worked on the product development teams at Fresenius, Sagent Pharmaceuticals and Cubist Pharma. He holds a Ph.D. and a Master of Science in Pharmaceutics and Drug Delivery from the Massachusetts College of Pharmacy and Health Sciences, along with an MBA from Northwestern University's Kellogg School of Management.

“We are excited to welcome Chris and Dev to Lucid’s equity research team. Chris and Dev bring extensive industry and research experience to the Lucid Healthcare Group, showcasing Lucid’s dedication to providing top-tier expertise. Lucid is thrilled to further strengthen its equity research team following the recent additions of Eric Zwick, covering specialty finance, and Craig Kucera, specializing in REITs,” said David Rosenberg, CEO Lucid Capital Markets - IB.

ABOUT LUCID CAPITAL MARKETS

Lucid is a full-service middle-market investment bank specializing in a broad range of financial services across various growth sectors of the economy. With decades of experience, our senior leadership has developed a client-focused and relationship-driven approach to our business, prioritizing success by tailoring solutions to each client's needs.

At its core, Lucid's main priority is building and maintaining relationships, ensuring every client receives the highest level of personal attention from senior professionals who strive to exceed expectations. Our team's professional experience across M&A advisory, capital markets, equity research, floor brokerage and institutional sales & trading enables Lucid to provide unmatched expertise.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.75
-8.91 (-3.34%)
AAPL  352.78
-3.49 (-0.98%)
AMD  504.28
-29.78 (-5.58%)
BAC  50.08
-0.94 (-1.84%)
GOOG  281.26
-11.26 (-3.85%)
META  626.41
-15.28 (-2.38%)
MSFT  517.99
-5.89 (-1.12%)
NVDA  156.14
-6.71 (-4.12%)
ORCL  119.09
-6.26 (-4.99%)
TSLA  379.74
-10.48 (-2.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback